Article Details
Retrieved on: 2018-03-01 16:40:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Switzerland-based pharma company Roche's $1.9 billion purchase of tech company <b>Flatiron Health</b> signifies Big Pharma's need for data, according to industry watchers. In what the company calls a move toward a personalized healthcare strategy, Roche will acquire oncology-specific electronic health ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here